Aaron Gerds, MD, on Using an AI System to Identify Patients Eligible for a Polycythemia Vera Trial

Aaron Gerds, MD, of Cleveland Clinic, reviews results of an evaluation of Synapsis AI, a medically trained, large language model–based end-to-end system, focusing on its accuracy and efficiency in identifying eligible patients for an active phase III polycythemia vera clinical trial (Abstract 4340).